Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021)
Lemaitre Vascular's (LMAT) quarterly Short term Debt came in at $3.0 million in Q2 2021, down 88.0% year-over-year from $25.0 million in Q2 2020, and up 9.09% quarter-over-quarter from $2.8 million in Q1 2021.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Short term Debt (2020 - 2021) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Short term Debt for 2 consecutive years, with $3.0 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Short term Debt fell 88.0% year-over-year to $3.0 million in Q2 2021; TTM through Jun 2021 was $3.0 million, a 88.0% decrease from a year earlier, with the FY2020 full-year figure at $2.5 million, changed N/A from the prior year.
- Short term Debt was $3.0 million for Q2 2021 at Lemaitre Vascular, up from $2.8 million in the prior quarter.
- Over five years, Short term Debt peaked at $25.0 million in Q2 2020 and troughed at $2.5 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.75 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 21.00 Mn |
| Jun 30, 2020 | 25.00 Mn |